Oral Vinorelbine: A Feasible and Safe Partner for Radiotherapy in the Treatment of Locally Advanced Non-Small Cell Lung Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s103645
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Feasibility of Stereotactic Body Radiotherapy for Locally-Advanced Non-Small Cell Lung Cancer

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Metronomic Treatment of Advanced Non-Small-Cell Lung Cancer With Daily Oral Vinorelbine &Ndash; A Phase I Trial

OncoTargets and Therapy
OncologyPharmacology
2017English

A Current Review of Dose-Escalated Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer

Radiology and Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Local Radiotherapy Intensification for Locally Advanced Non–small-Cell Lung Cancer – A Call to Arms

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Is Video-Assisted Thoracic Lobectomy Safe and Successful for Locally Advanced Non–small Cell Lung Cancer?

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2013English

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

P2.17-07 Concurrent Chemoradiotherapy (ConCRT) Using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy